Healthy volunteers test new tamper-resistant painkiller combo
NCT ID NCT06500793
First seen Mar 11, 2026 · Last updated May 17, 2026 · Updated 15 times
Summary
This early-stage study tests how a new painkiller (PF614) moves through the body when taken alone or with another drug (nafamostat). Thirty healthy adults aged 18 to 55 will receive a single dose, and researchers will measure drug levels in the blood over time. The goal is to understand the drug's behavior, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quotient Sciences
RECRUITINGMiami, Florida, 33126, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.